GSK heart drug flops in study, shingles vaccine on track

LONDON (Reuters) - An experimental heart drug from GlaxoSmithKline failed to work as hoped in the first part of a large clinical trial, the company said on Tuesday, dealing a blow to its pipeline of new medicines.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news